Alkermes
ALKS
#3093
Rank
ยฃ3.65 B
Marketcap
ยฃ22.14
Share price
0.75%
Change (1 day)
-10.27%
Change (1 year)

Revenue for Alkermes (ALKS)

Revenue in 2025 (TTM): ยฃ1.15 Billion

According to Alkermes's latest financial reports the company's current revenue (TTM ) is ยฃ1.14 Billion. In 2024 the company made a revenue of ยฃ1.24 Billion a decrease over the revenue in the year 2023 that were of ยฃ1.30 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alkermes from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ1.15 B-6.74%
2024 ยฃ1.24 B-4.93%
2023 ยฃ1.30 B42.07%
2022 ยฃ0.91 B5.69%
2021 ยฃ0.86 B14.1%
2020 ยฃ0.76 B-14.66%
2019 ยฃ0.89 B3.58%
2018 ยฃ0.86 B28.97%
2017 ยฃ0.66 B10.6%
2016 ยฃ0.60 B42.53%
2015 ยฃ0.42 B6.68%
2014 ยฃ0.39 B
2012 ยฃ0.33 B67.97%
2011 ยฃ0.19 B77.34%
2010 ยฃ0.11 B-0.71%
2009 ยฃ0.11 B-51.83%
2008 ยฃ0.23 B92.53%
2007 ยฃ0.12 B4.79%
2006 ยฃ0.11 B48.12%
2005 ยฃ78.85 M118.84%
2004 ยฃ36.03 M82.69%
2003 ยฃ19.72 M-33.53%
2002 ยฃ29.67 M-16.21%
2001 ยฃ35.41 M18.69%
2000 ยฃ29.83 M93.79%
1999 ยฃ15.39 M-44.56%
1998 ยฃ27.77 M62.99%
1997 ยฃ17.03 M59.37%
1996 ยฃ10.69 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Acorda Therapeutics
ACOR
ยฃ86.75 M-92.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ36.02 B 3,057.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.11 B 5,957.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.09 B 4,027.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ43.59 B 3,720.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
ยฃ12.58 B 1,002.71%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
ยฃ61.27 M-94.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ35.64 B 3,023.90%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
ยฃ42.28 B 3,605.42%๐Ÿ‡จ๐Ÿ‡ญ Switzerland